These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 24408894)

  • 1. Imaging integrin αvβ3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts.
    Terry SY; Abiraj K; Frielink C; van Dijk LK; Bussink J; Oyen WJ; Boerman OC
    J Nucl Med; 2014 Feb; 55(2):281-6. PubMed ID: 24408894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can 111In-RGD2 monitor response to therapy in head and neck tumor xenografts?
    Terry SY; Abiraj K; Lok J; Gerrits D; Franssen GM; Oyen WJ; Boerman OC
    J Nucl Med; 2014 Nov; 55(11):1849-55. PubMed ID: 25349221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.
    Liu Z; Jia B; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
    Bioconjug Chem; 2010 Mar; 21(3):548-55. PubMed ID: 20184307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does imaging αvβ3 integrin expression with PET detect changes in angiogenesis during bevacizumab therapy?
    Rylova SN; Barnucz E; Fani M; Braun F; Werner M; Lassmann S; Maecke HR; Weber WA
    J Nucl Med; 2014 Nov; 55(11):1878-84. PubMed ID: 25278514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Characterization of 4
    Lobeek D; Franssen GM; Ma MT; Wester HJ; Decristoforo C; Oyen WJG; Boerman OC; Terry SYA; Rijpkema M
    J Nucl Med; 2018 Aug; 59(8):1296-1301. PubMed ID: 29626124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of biological properties of (111)In-labeled dimeric cyclic RGD peptides.
    Zheng Y; Ji S; Tomaselli E; Yang Y; Liu S
    Nucl Med Biol; 2015 Feb; 42(2):137-45. PubMed ID: 25459111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (99m)Tc-3P-RGD2 micro-single-photon emission computed tomography/computed tomography provides a rational basis for integrin αvβ3-targeted therapy.
    Fu T; Qu W; Qiu F; Li Y; Shao G; Tian W; Hua Z; Zhang Y; Wang F
    Cancer Biother Radiopharm; 2014 Nov; 29(9):351-8. PubMed ID: 25286251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early response monitoring with 18F-FDG PET and cetuximab-F(ab')2-SPECT after radiotherapy of human head and neck squamous cell carcinomas in a mouse model.
    van Dijk LK; Boerman OC; Franssen GM; Lok J; Kaanders JH; Bussink J
    J Nucl Med; 2014 Oct; 55(10):1665-70. PubMed ID: 25236350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
    Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
    J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
    Yoshimoto M; Ogawa K; Washiyama K; Shikano N; Mori H; Amano R; Kawai K
    Int J Cancer; 2008 Aug; 123(3):709-15. PubMed ID: 18498129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the RGD Motif-Containing α
    Roesch S; Lindner T; Sauter M; Loktev A; Flechsig P; Müller M; Mier W; Warta R; Dyckhoff G; Herold-Mende C; Haberkorn U; Altmann A
    J Nucl Med; 2018 Nov; 59(11):1679-1685. PubMed ID: 29674419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 111In-cetuximab-F(ab')2 SPECT imaging for quantification of accessible epidermal growth factor receptors (EGFR) in HNSCC xenografts.
    van Dijk LK; Hoeben BA; Stegeman H; Kaanders JH; Franssen GM; Boerman OC; Bussink J
    Radiother Oncol; 2013 Sep; 108(3):484-8. PubMed ID: 23932156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging.
    Hu K; Tang X; Tang G; Yao S; Yao B; Wang H; Nie D; Liang X; Tang C; He S
    PLoS One; 2015; 10(9):e0138675. PubMed ID: 26397833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck.
    Beer AJ; Grosu AL; Carlsen J; Kolk A; Sarbia M; Stangier I; Watzlowik P; Wester HJ; Haubner R; Schwaiger M
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6610-6. PubMed ID: 18006761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microPET imaging of glioma integrin {alpha}v{beta}3 expression using (64)Cu-labeled tetrameric RGD peptide.
    Wu Y; Zhang X; Xiong Z; Cheng Z; Fisher DR; Liu S; Gambhir SS; Chen X
    J Nucl Med; 2005 Oct; 46(10):1707-18. PubMed ID: 16204722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptides.
    Yang Y; Ji S; Liu S
    Bioconjug Chem; 2014 Sep; 25(9):1720-9. PubMed ID: 25144854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
    Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
    Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an Integrin α
    Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
    Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma model.
    Hoeben BA; Molkenboer-Kuenen JD; Oyen WJ; Peeters WJ; Kaanders JH; Bussink J; Boerman OC
    Int J Cancer; 2011 Aug; 129(4):870-8. PubMed ID: 20957635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of epidermal growth factor receptor expression in head and neck cancer with SPECT/CT and 111In-labeled cetuximab-F(ab')2.
    van Dijk LK; Hoeben BA; Kaanders JH; Franssen GM; Boerman OC; Bussink J
    J Nucl Med; 2013 Dec; 54(12):2118-24. PubMed ID: 24136932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.